Clinical benefits for CRT-D over ICD even with comorbidity

May 10, 2017

(HealthDay)—For patients with left bundle branch block, the benefit of cardiac resynchronization therapy with defibrillator (CRT-D) over implantable cardioverter-defibrillator (ICD) alone persists with comorbidity, according to a study published in the May 16 issue of the Journal of the American College of Cardiology.

Emily P. Zeitler, M.D., from Duke University Hospital in Durham, N.C., and colleagues examined the correlation of multiple comorbidities with the benefits of CRT-D over ICD alone in 1,214 patients with left bundle branch block and zero, one, two, or three or more comorbidities.

The researchers identified an inverse correlation between comorbidity burden and improvements in left ventricular (LV) end-systolic volume, LV end-diastolic volume, LV ejection fraction, left atrial volume, and LV dyssynchrony. Regardless of treatment group, there was an increasing risk of death or nonfatal heart failure events with increasing comorbidity burden in an adjusted model (P < 0.001). There was no interaction with respect to comorbidity burden and the benefit of CRT-D versus ICD only for death or nonfatal heart failure events during a mean follow-up of 4.65 years (interaction, P = 0.943). The absolute risk reduction associated with CRT-D versus ICD alone was greater for groups with the greatest comorbidity burden versus those with less comorbidity burden (2 and ≥3 versus 0 and 1).

"The burden of comorbidity does not appear to compromise the clinical benefits of CRT-D compared with ICD alone," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical device industries.

Explore further: Adding defibrillator to CRT no benefit in dilated cardiomyopathy

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Adding defibrillator to CRT no benefit in dilated cardiomyopathy

April 3, 2017
(HealthDay)—For patients with heart failure with indications for cardiac resynchronization therapy (CRT), those with ischemic cardiomyopathy (ICM), but not those with nonischemic dilated cardiomyopathy (DCM), benefit from ...

Prostate cancer interacts with comorbidity to increase VTE rate

July 21, 2015
(HealthDay)—For men with prostate cancer (PC), the rate of venous thromboembolism (VTE) is increased with high comorbidity, according to a study published online July 6 in Cancer.

Longer LOS for new heart failure in medicaid patients

March 4, 2014
(HealthDay)—Medicaid patients and patients with more comorbidities have a longer length of stay (LOS) for incident heart failure, compared to other hospitalized cases, according to a study published in the January/February ...

Chronic kidney disease patients benefit from pacing left and right ventricles

December 7, 2015
Patients with moderate-to-severe chronic kidney disease who received cardiac resynchronization therapy with defibrillator had a lower risk of hospitalization for heart failure or death from this condition compared to patients ...

PR interval prognostic of cardiac resynchronization Tx outcome

February 15, 2017
(HealthDay)—For patients with advanced systolic heart failure, the impact of cardiac resynchronization therapy with defibrillation (CRT-D) varies according to PR interval, according to research published in the February ...

Comorbid conditions associated with worse lung cancer survival

June 11, 2015
Main Findings: Lung cancer patients with comorbid conditions such as chronic obstructive pulmonary disease, diabetes, or congestive heart failure had a higher risk of death than lung cancer patients without comorbid conditions.

Recommended for you

Effective drug delivery to heart with tannic acid

September 18, 2018
Typical methods of drug delivery to the heart require surgical procedures involving incisions in the chest wall and bones. To efficiently treat cardiovascular and related vascular diseases without surgery, a KAIST research ...

Daily low-dose aspirin found to have no effect on healthy life span in older people

September 16, 2018
In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia ...

Financial incentives for cholesterol control may be cost-effective

September 14, 2018
A program that offered financial incentives to both patients and their physicians to control low-density lipoproteins (LDL) cholesterol could be a cost-effective intervention for patients at high risk of cardiovascular disease ...

Apple's smartwatch has a heart monitor now

September 13, 2018
There will soon be another way to monitor your heart—from your wrist.

3-D virtual simulation gets to the 'heart' of irregular heartbeats

September 12, 2018
In a proof of concept study, scientists at Johns Hopkins report they have successfully performed 3-D personalized virtual simulations of the heart to accurately identify where cardiac specialists should electrically destroy ...

Dairy consumption linked to lower rates of cardiovascular disease and mortality

September 12, 2018
Dairy consumption of around three servings per day is associated with lower rates of cardiovascular disease and mortality, compared to lower levels of consumption, according to a global observational study of over 130,000 ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.